Physician profile
Sean Bhalla
NPI 1912311325
$3,692.16
in general payments reported to CMS, 2019-2025
11 companies · $560 in 2025
The $560 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $36.82 · 2022: $680 · 2023: $1,080 · 2024: $1,335 · 2025: $560.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,954 · Travel and Lodging: $1,021.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,953.52 |
| Travel and Lodging | $1,021.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,636.10 | 2022-2025 | Axios, Spyglass, Exalt Model D |
| Olympus Corporation of The Americas | $536.78 | 2024 | Single Use Electrosurgical Knife Kd-655, Disposable Distal Attachment, Olympus |
| Ovesco Endoscopy USA, INC. | $521.92 | 2023 | |
| Fujifilm Healthcare Americas Corporation | $255.17 | 2025 | |
| Pentax of America, INC. | $168.67 | 2022 | |
| Conmed Corporation | $154.74 | 2024 | Conmed Biliary |
| Apollo Endosurgery US INC | $144.71 | 2022 | |
| Cook Medical LLC | $104.04 | 2021-2024 | Hemospray |
| Erbe USA INC | $75.00 | 2022 | |
| Olympus America INC. | $63.81 | 2024 | Endoclot Phs |
| Creo Medical INC. | $31.22 | 2024 | Speedboat Ultraslim (Sb1l) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Bhalla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.